We identified serum copeptin, KIM-1 and urinary Pb levels with eGFR as well as ACE I/D gene polymorphism that could affect DN progression in T2DM either smokers and non-smokers individuals. The gene discussed is AVP; the disease is type 2 diabetes mellitus.